Article Information
History
- January 16, 2024.
Article Versions
- You are currently viewing Version 1 of this article (January 16, 2024 - 08:36).
- Version 2 (January 17, 2024 - 15:26).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lovedeep S Dhingra, MBBS1,*,
- Veer Sangha, BS1,2,*,
- Arya Aminorroaya, MD, MPH1,
- Robyn Bryde, MD3,4,
- Andrew Gaballa, MD5,
- Adel H Ali, MD5,
- Nandini Mehra, MD5,
- Harlan M. Krumholz, MD SM1,6,
- Sounok Sen, MD1,
- Christopher M Kramer, MD7,
- Matthew W Martinez, MD3,4,
- Milind Y Desai, MD, MBA5,
- Evangelos K Oikonomou, MD, DPhil1 and
- Rohan Khera, MD, MS1,6,8,†
- 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 2Department of Engineering Science, Oxford University, Oxford, UK
- 3Department of Cardiovascular Medicine, Atlantic Health, Morristown Medical Center, Morristown, NJ, USA
- 4Sports Cardiology and Hypertrophic Cardiomyopathy, Morristown Medical Center, Morristown, NJ, USA
- 5Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
- 6Center for Outcomes Research and Evaluation (CORE), Yale New Haven Hospital, New Haven, CT, USA
- 7Cardiovascular Division, Department of Medicine, University of Virginia Health, Charlottesville, VA, USA
- 8Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
- ↵†Correspondence to:
Rohan Khera, MD, MS, 195 Church Street, 6th Floor, New Haven, CT 06510, rohan.khera{at}yale.edu
↵* Contributed equally
Posted January 16, 2024.
A Multicenter Evaluation of the Impact of Procedural and Pharmacological Interventions on Deep Learning-based Electrocardiographic Markers of Hypertrophic Cardiomyopathy
